TP53 can reduce gluconeogenesis by down-regulating the expression of G6PC gene in colon and liver cancer cells and in vivo, thus implying an important regulatory relationship between TP53 and G6PC gene (Zhang et al., 2014). This evidence concerns the gene G6PC1 and liver cancer.